|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM346194105 |
| 003 |
DE-627 |
| 005 |
20231226030833.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231226s2022 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1021/acs.langmuir.2c01909
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n1153.xml
|
| 035 |
|
|
|a (DE-627)NLM346194105
|
| 035 |
|
|
|a (NLM)36102591
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Wang, Jiawei
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a "Willow Branch" DNA Self-Assembly for Cancer Dual-Target and Proliferation Inhibition
|
| 264 |
|
1 |
|c 2022
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 28.09.2022
|
| 500 |
|
|
|a Date Revised 13.10.2022
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a DNA nanotechnology is beginning to yield unique advantages in the area of drug delivery. For the dual-targeting and proliferation suppression of cancer cells, a "willow branch" DNA assembly based on rolling circle amplification (RCA) was built. Three single-stranded DNAs, including antibody modified cDNAs, aptamer cDNAs, and simple cDNAs, were employed in the DNA self-assembly, along with the RCA scaffolds (every 63 bases is a repeat unit). "Willow branch" DNA (WB DNA) assembly successfully linked multiple antibodies and aptamers together to achieve dual targeting of cancer cells. Binding of CD44 antibodies and S2.2 aptamers to receptors on the cell membrane inhibits both pathways, β-catenin signaling and nuclear factor-kappa B-specific transcription activity, through feedback regulation. Results demonstrated that WB DNA assembly could effectively exert multivalency clustering cell-surface receptors, modulating signal pathways and inhibiting proliferation. This study proposes a new approach for cancer dual-target and proliferation inhibition by clustering multivalent receptors
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
| 650 |
|
7 |
|a Antibodies
|2 NLM
|
| 650 |
|
7 |
|a Aptamers, Nucleotide
|2 NLM
|
| 650 |
|
7 |
|a DNA, Single-Stranded
|2 NLM
|
| 650 |
|
7 |
|a Oligonucleotides
|2 NLM
|
| 650 |
|
7 |
|a beta Catenin
|2 NLM
|
| 650 |
|
7 |
|a DNA
|2 NLM
|
| 650 |
|
7 |
|a 9007-49-2
|2 NLM
|
| 700 |
1 |
|
|a Zhang, Zhiqing
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Zhang, Ruyan
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Du, Huan
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Zhou, Ting
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Wang, Fang
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Langmuir : the ACS journal of surfaces and colloids
|d 1999
|g 38(2022), 38 vom: 27. Sept., Seite 11778-11786
|w (DE-627)NLM098181009
|x 1520-5827
|7 nnns
|
| 773 |
1 |
8 |
|g volume:38
|g year:2022
|g number:38
|g day:27
|g month:09
|g pages:11778-11786
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1021/acs.langmuir.2c01909
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_22
|
| 912 |
|
|
|a GBV_ILN_350
|
| 912 |
|
|
|a GBV_ILN_721
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 38
|j 2022
|e 38
|b 27
|c 09
|h 11778-11786
|